» Articles » PMID: 37632105

MDM2 Influences ACE2 Stability and SARS-CoV-2 Uptake

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2023 Aug 26
PMID 37632105
Authors
Affiliations
Soon will be listed here.
Abstract

Angiotensin-converting enzyme 2 (ACE2) is the central entry receptor for SARS-CoV-2. However, surprisingly little is known about the effects of host regulators on ACE2 localization, expression, and the associated influence on SARS-CoV-2 infection. Here we identify that ACE2 expression levels are regulated by the E3 ligase MDM2 and that MDM2 levels indirectly influence infection with SARS-CoV-2. Genetic depletion of MDM2 elevated ACE2 expression levels, which strongly promoted infection with all SARS-CoV-2 isolates tested. SARS-CoV-2 spike-pseudotyped viruses and the uptake of non-replication-competent virus-like particles showed that MDM2 affects the viral uptake process. MDM2 ubiquitinates Lysine 788 of ACE2 to induce proteasomal degradation, and degradation of this residue led to higher ACE2 expression levels and superior virus particle uptake. Our study illustrates that cellular regulators of ACE2 stability, such as MDM2, play an important role in defining the infection capabilities of SARS-CoV-2.

Citing Articles

Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses.

Ridgway H, Apostolopoulos V, Moore G, Kate Gadanec L, Zulli A, Swiderski J Viruses. 2024; 16(11).

PMID: 39599890 PMC: 11599072. DOI: 10.3390/v16111776.


A viral attack on brain tumors: the potential of oncolytic virus therapy.

Mokhtarpour K, Akbarzadehmoallemkolaei M, Rezaei N J Neurovirol. 2024; 30(3):229-250.

PMID: 38806994 DOI: 10.1007/s13365-024-01209-8.


Ganciclovir as a potential treatment for glioma: a systematic review and meta-analysis.

Chang C, Chen H, Chuang C, Chang S, Hsiao N J Neurooncol. 2023; 165(3):399-411.

PMID: 38066255 DOI: 10.1007/s11060-023-04503-3.

References
1.
DArdes D, Boccatonda A, Rossi I, Guagnano M, Santilli F, Cipollone F . COVID-19 and RAS: Unravelling an Unclear Relationship. Int J Mol Sci. 2020; 21(8). PMC: 7215550. DOI: 10.3390/ijms21083003. View

2.
Schaecher S, Mackenzie J, Pekosz A . The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles. J Virol. 2006; 81(2):718-31. PMC: 1797472. DOI: 10.1128/JVI.01691-06. View

3.
He W, Liu X, Hu B, Li D, Chen L, Li Y . Mechanisms of SARS-CoV-2 Infection-Induced Kidney Injury: A Literature Review. Front Cell Infect Microbiol. 2022; 12:838213. PMC: 9237415. DOI: 10.3389/fcimb.2022.838213. View

4.
Pichlmair A, Lassnig C, Eberle C, Gorna M, Baumann C, Burkard T . IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat Immunol. 2011; 12(7):624-30. DOI: 10.1038/ni.2048. View

5.
Wang G, Zhao Q, Zhang H, Liang F, Zhang C, Wang J . Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells. Front Med. 2021; 15(2):252-263. PMC: 7843238. DOI: 10.1007/s11684-021-0837-6. View